v3.26.1
Business Segments
 3 Months Ended
Apr. 04, 2026
Segment Reporting [Abstract]  
Business Segments

13. Business Segments

The Company operates in one segment: ophthalmology. The Company develops, manufactures and markets medical devices. The Company’s revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows (in thousands):

 

 

 

Three Months Ended

 

 

 

April 4, 2026

 

 

March 29, 2025

 

Cyclo G6

 

$

3,643

 

 

$

3,181

 

Retina

 

 

5,827

 

 

 

6,645

 

Other(1)

 

 

2,329

 

 

 

2,070

 

Total revenues

 

$

11,799

 

 

$

11,896

 

(1) Includes service contract revenues of $349 thousand and $334 thousand recognized during the three months ended April 4, 2026 and March 29, 2025, respectively. Includes $364 thousand recognized revenue related to the exclusive distribution rights during both of the three months ended April 4, 2026 and March 29, 2025. Other also includes revenues from paid service, royalty, freight and legacy G probes.

 

Revenue information shown by geographic region, based on the sales destination, is as follows (in thousands):

 

 

 

Three Months Ended

 

 

 

April 4, 2026

 

 

March 29, 2025

 

United States

 

$

5,869

 

 

$

5,283

 

Europe, Middle East and Africa

 

 

3,341

 

 

 

2,861

 

Asia/Pacific Rim

 

 

2,039

 

 

 

3,360

 

Americas, excluding the U.S.

 

 

550

 

 

 

392

 

 

 

$

11,799

 

 

$

11,896

 

 

Revenues are attributed to countries based on the location of end customers.

The United States accounted for 49.7% and 44.4% of revenues for the three months ended April 4, 2026 and March 29, 2025, respectively. Other than the United States, the Netherlands accounted for at least 10% of the Company’s revenues during the three months ended April 4, 2026 and March 29, 2025, representing 15.4% and 13.1%, respectively.